[go: up one dir, main page]

MX2017012596A - Una composicion farmaceutica y el uso de la misma. - Google Patents

Una composicion farmaceutica y el uso de la misma.

Info

Publication number
MX2017012596A
MX2017012596A MX2017012596A MX2017012596A MX2017012596A MX 2017012596 A MX2017012596 A MX 2017012596A MX 2017012596 A MX2017012596 A MX 2017012596A MX 2017012596 A MX2017012596 A MX 2017012596A MX 2017012596 A MX2017012596 A MX 2017012596A
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
composition
well
relates
present
Prior art date
Application number
MX2017012596A
Other languages
English (en)
Other versions
MX389026B (es
Inventor
Chantalat Laurent
Andres Philippe
Original Assignee
Galderma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Sa filed Critical Galderma Sa
Publication of MX2017012596A publication Critical patent/MX2017012596A/es
Publication of MX389026B publication Critical patent/MX389026B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/19—Acanthaceae (Acanthus family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/19—Acanthaceae (Acanthus family)
    • A61K36/195—Strobilanthes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A61K36/315—Isatis, e.g. Dyer's woad
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica, así como al uso de la composición en aplicaciones médicas.
MX2017012596A 2015-04-09 2016-04-08 Una composicion farmaceutica y el uso de la misma. MX389026B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15163061 2015-04-09
PCT/EP2016/057763 WO2016162485A1 (en) 2015-04-09 2016-04-08 A pharmaceutical composition and the use thereof

Publications (2)

Publication Number Publication Date
MX2017012596A true MX2017012596A (es) 2018-01-09
MX389026B MX389026B (es) 2025-03-20

Family

ID=52874983

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017012596A MX389026B (es) 2015-04-09 2016-04-08 Una composicion farmaceutica y el uso de la misma.

Country Status (11)

Country Link
US (3) US10232006B2 (es)
EP (1) EP3209314B1 (es)
JP (1) JP6749935B2 (es)
KR (1) KR20170132880A (es)
CN (1) CN107466234A (es)
AU (1) AU2016245204B2 (es)
BR (1) BR112017021190B1 (es)
CA (1) CA2980667A1 (es)
MX (1) MX389026B (es)
TW (1) TWI737602B (es)
WO (1) WO2016162485A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170132880A (ko) * 2015-04-09 2017-12-04 갈데르마 소시에떼아노님 약학 조성물 및 이의 용도
WO2016162490A1 (en) 2015-04-09 2016-10-13 Galderma Sa Antibacterial indigo naturalis or indigo-producing plant extract and use thereof
PT3209313T (pt) 2015-04-09 2019-02-07 Galderma Sa Extracto de indigo naturalis e um processo para a preparação do mesmo
KR20180071987A (ko) * 2016-12-20 2018-06-28 서울대학교병원 청대 추출물 또는 이의 분획물을 유효성분으로 포함하는 염증성 장질환의 예방 또는 치료용 약학적 조성물
KR102222919B1 (ko) * 2018-07-06 2021-03-04 주식회사 씨케이바이오텍 인디루빈 유도체를 유효성분으로 포함하는 상처 예방 또는 치료용 약학 조성물
CN114206312A (zh) 2019-04-17 2022-03-18 阿佐拉治疗股份有限公司 用于治疗炎性皮肤病的局部组合物和方法
WO2020227151A1 (en) 2019-05-03 2020-11-12 Azora Therapeutics, Inc. Compositions comprising indigo and/or an indigo derivative and methods of use thereof
US11345818B1 (en) 2020-12-29 2022-05-31 Industrial Technology Research Institute Dye for fiber and dyeing method

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02264727A (ja) 1989-04-04 1990-10-29 Ichimaru Pharcos Co Ltd 植物抽出物からなる過酸化脂質生成抑制剤
US6524625B2 (en) 1998-06-30 2003-02-25 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyuto Physiologically active extract obtained from indigo plant polygonum tinctorium
CA2369448C (en) * 1999-04-14 2008-08-19 Max Zeller Sohne Ag Medicament for inhibiting nf-kb
CN1317322A (zh) 2000-04-11 2001-10-17 汤仪 炎疣液
JP5452827B2 (ja) * 2000-10-30 2014-03-26 株式会社ファンケル 皮膚賦活用組成物
US20030054047A1 (en) * 2001-06-15 2003-03-20 Sanjiu Medical & Pharmaceutical Co., Ltd. Pharmaceutical composition for the treatment of viral infection
JP2003002989A (ja) * 2001-06-19 2003-01-08 Toray Ind Inc プリプレグ
US7572469B2 (en) 2002-04-15 2009-08-11 Tetsuo Santo Therapeutic lotion for dermatitis
US7615239B2 (en) 2002-04-15 2009-11-10 Tetsuo Santo Tea for treating dermatitis comprising herbal extracts
CN1316996C (zh) * 2002-12-26 2007-05-23 中国医科大学附属第一医院 治疗炎性肠病的复方青黛剂及制备方法
KR20050077310A (ko) 2004-01-27 2005-08-02 주식회사 엘지생활건강 인디고 추출물을 이용한 모발, 눈썹 및 속눈썹 성장촉진제
CN1586506A (zh) 2004-06-29 2005-03-02 邹卫民 降白口服液
JP5023317B2 (ja) 2005-03-03 2012-09-12 国立大学法人弘前大学 Ｉｖ型アレルギー反応抑制剤
JP2007326855A (ja) 2006-05-11 2007-12-20 Mitsubishi Gas Chem Co Inc 新規配糖体
CN101541340A (zh) * 2006-11-24 2009-09-23 株式会社林原生物化学研究所 蓝草提取物粉末及其制造方法、以及该蓝草提取物粉末的用途
JP5797565B2 (ja) 2009-03-11 2015-10-21 プロメディオール， インコーポレイテッド 過敏性障害（ｈｙｐｅｒｓｅｎｓｉｔｉｖｅ ｄｉｓｏｒｄｅｒ）に対する処置および診断方法
CN102247415B (zh) 2010-05-21 2013-09-04 成都中医药大学 一种青黛炮制方法
TWI438000B (zh) * 2011-02-18 2014-05-21 Galderma Res & Dev 青黛之經油萃取的產物及其製備方法與用途
TWI468169B (zh) * 2011-02-18 2015-01-11 Galderma Res & Dev 青黛之經油萃取的產物及其製備方法與用途
JP5933525B2 (ja) 2011-03-14 2016-06-08 サンスター株式会社 藍葉エキス製造方法
AR086915A1 (es) 2011-06-17 2014-01-29 Nycomed Gmbh Derivados de ftalazinona-pirrolopirimidinacarboxamida y composiciones farmaceuticas que los contiene
CN102351863A (zh) * 2011-10-10 2012-02-15 南京泽朗医药科技有限公司 一种从菘蓝中提取青黛酮的方法
KR20130071857A (ko) 2011-12-21 2013-07-01 원효정 쪽과 황칠나무 추출물을 유효성분으로 포함하는 물티슈 및 일회용 흡수제품과 이의 제조방법
CN103766415A (zh) 2012-10-17 2014-05-07 天津市中科健新材料技术有限公司 一种含壳聚糖的草本抗菌剂
WO2014118040A1 (en) * 2013-01-29 2014-08-07 Axel Brattstroem Extract from indigo tinctoria for the topical treatment and prophylaxis of skin disorders
US20140243354A1 (en) * 2013-02-22 2014-08-28 Galderma Research & Development Snc Combinations of indigo naturalis and berberine and uses thereof
EP2961385A4 (en) 2013-02-28 2016-07-27 Prec Dermatology Inc TOPICAL FORMULATIONS OF CORTICOSTEROIDS WITH INCREASED BIOAVAILABILITY
JP6161438B2 (ja) 2013-07-09 2017-07-12 日本甜菜製糖株式会社 脂肪蓄積抑制及び／又は脂肪蓄積量低減剤
CN103992260A (zh) * 2014-05-29 2014-08-20 哈尔滨医科大学 一种从大青叶中提取靛玉红的方法
CN104147309B (zh) 2014-08-13 2017-12-05 天津开发区天光高科技开发有限公司 一种盐藻素营养组合物及其制备方法
WO2016162490A1 (en) * 2015-04-09 2016-10-13 Galderma Sa Antibacterial indigo naturalis or indigo-producing plant extract and use thereof
PT3209313T (pt) * 2015-04-09 2019-02-07 Galderma Sa Extracto de indigo naturalis e um processo para a preparação do mesmo
JP6803849B2 (ja) * 2015-04-09 2020-12-23 ガルデルマ・ソシエテ・アノニム インジゴナチュラリス又はインジゴ産生植物の抽出物を用いたアトピー性皮膚炎の処置
KR20170132880A (ko) * 2015-04-09 2017-12-04 갈데르마 소시에떼아노님 약학 조성물 및 이의 용도

Also Published As

Publication number Publication date
BR112017021190B1 (pt) 2021-12-21
EP3209314B1 (en) 2021-11-10
US20200147163A1 (en) 2020-05-14
US20190160128A1 (en) 2019-05-30
WO2016162485A1 (en) 2016-10-13
US20170304381A1 (en) 2017-10-26
EP3209314A1 (en) 2017-08-30
KR20170132880A (ko) 2017-12-04
AU2016245204B2 (en) 2021-07-29
US11116811B2 (en) 2021-09-14
JP2018510889A (ja) 2018-04-19
MX389026B (es) 2025-03-20
BR112017021190A2 (pt) 2018-09-25
TW201701893A (zh) 2017-01-16
AU2016245204A1 (en) 2017-10-12
CN107466234A (zh) 2017-12-12
US10232006B2 (en) 2019-03-19
TWI737602B (zh) 2021-09-01
CA2980667A1 (en) 2016-10-13
JP6749935B2 (ja) 2020-09-02
US10555985B2 (en) 2020-02-11

Similar Documents

Publication Publication Date Title
CL2023001911A1 (es) Derivado de glucagón y una composición que comprende un conjugado de acción prolongada del mismo
CO2018005525A2 (es) Formulación farmacéutica acuosa del anticuerpo anti-pd-l1 avelumab
CO2017008079A2 (es) Composiciones para el cuidado bucal y métodos de uso
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
CL2016002269A1 (es) Moduladores alostéricos del núcleo proteico de la hepatitis b.
JOP20140114B1 (ar) مركبات حلقية غير متجانسة واستخداماتها
CL2016000153A1 (es) Derivados de pirrolamida sustituidos con glioxamida y su uso como medicamentos para el tratamiento de la hepatitis b
MX378273B (es) Compuestos activos hacia bromodominios.
EA201591887A1 (ru) Макроциклические деазаоксипурины для лечения вирусных инфекций
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
MX2020012132A (es) Compuestos de azapiridona y usos de los mismos.
CL2015001985A1 (es) Compuestos de tiazolcarboxamidas y piridinacarboxamida, inhibidores de quinasa pim.
MX2016008448A (es) Conjugados de var2csa-farmaco.
CL2015002897A1 (es) Inhibidores de bace1
MX2015012833A (es) Composiciones antibioticas de ceftolozano.
MX2023006415A (es) Anticuerpos, usos y metodos.
MX389178B (es) Formulacion de proporcion fija de insulina glargina/lixisenatida.
DOP2017000058A (es) Derivados de tetrahidroquinolina como inhibidores del bromodominio
MX384131B (es) Compuestos neurotransmisores de dihidroxifenilo, composiciones y métodos.
EA201791716A1 (ru) Фармацевтический состав
BR112014030720A8 (pt) composto, composição farmacêutica e usos de inibidores de fbx03
BR112017012608A2 (pt) composto, composição farmacêutica e uso de um composto
BR112017024126A2 (pt) composições farmacêuticas e uso das mesmas
TR201819130T4 (tr) Sulu Formülasyonlar, Bunların Üretimi Ve Kullanımı